Skip to content
Health areas

Skin Health

The skin is the organ of the human body which serves as a physical and immunological barrier.

Its health is closely linked not only to the skin microbiome, but also to the gut microbiome, forming what is often called the gut–skin axis. The gut microbiota influences skin health through metabolic, immune, and endocrine pathways.

Mechanisms include:

  • Immune modulation: Short-chain fatty acids (e.g., butyrate, acetate) regulate systemic inflammation and T-cell responses, influencing skin conditions.
  • Barrier function: A healthy gut reduces intestinal permeability (“leaky gut”), which prevents systemic inflammation that can exacerbate skin diseases.
  • Neuroendocrine signaling: Microbes produce neurotransmitters (e.g., GABA, serotonin precursors) that affect the stress response and, indirectly, skin inflammation.
  • Metabolites & vitamins: Gut microbes synthesize B vitamins, vitamin K, and bioactive metabolites that support skin repair and barrier function.

The gut–skin axis highlights the interplay between gut microbiota, systemic immunity, and the skin microbiome. The gut dysbiosis could induce clinical implications such as acne, atopic dermatitis, psioriasis. Microbial metabolites, especially short chain fatty acids and antioxidants may protect against oxidative stress and promote collagen synthesis that is important in skin aging.

Oral supplementation with probiotics may affect the gut dysbiosis and result in reducing inflammation, supporting barrier function, and modulating immune responses relevant to skin disorders.

Jimenez-Sanchez M, Celiberto LS, Yang H, Sham HP, Vallance BA. The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential. Gut Microbes. 2025, 17(1):2473524.

Lai X, Huang J, Li Y, Dong L. Symbiotic bacteria-mediated imbalance and repair of immune homeostasis: exploring novel mechanisms of microbiome-host interactions in atopic dermatitis. Front Immunol. 2025, 23;16:1649857.

Pachauri A, Sharma S. Unravelling the gut-skin axis: the role of gut microbiota in pathogenesis and management of psoriasis. Inflammopharmacology. 2025, 33(7):3671-3678.

Searle T, Al-Niaimi F, Ali FR. Modulation of the microbiome: a paradigm shift in the treatment of acne. Clin Exp Dermatol. 2025, 18:llaf328.

Wang Z, Yuan F, Zhong X, Feng S, Song T. Skin microbiome and skin aging: emerging strategies for manipulation. Microbiol Res. 2025, 300:128285.

Xue M, Deng Q, Deng L, Xun T, et al. Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review. Eur J Pharmacol. 2025, 5;998:177521.

Our studies

NORDBIOTIC™ studies are designed according to the rules of Evidence Based Medicine

Are you a company?
Learn more about our solutions.
Visit nordicbiotic.com

Powered by NORDBIOTIC™

Discover benefits of scientific grounds for your brand.

Contact us

    I want to receive news